Tudor Investment Corp
VIR icon

Tudor Investment Corp’s Vir Biotechnology VIR Stock Holding History

Tudor Investment Corp’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$659K Buy
73,504
+4,930
+7% +$39.3K ﹤0.01% 2646
2025
Q4 		$414K Buy
+68,574
New +$408K ﹤0.01% 2824
2025
Q2 		– Sell
-68,349
Closed -$443K – 4135
2025
Q1 		$443K Buy
+68,349
New +$608K ﹤0.01% 2351
2024
Q4 		– Sell
-68,113
Closed -$510K – 3790
2024
Q3 		$510K Buy
68,113
+209
+0.3% +$1.81K 0.01% 2022
2024
Q2 		$604K Buy
67,904
+3,089
+5% +$29.6K 0.01% 1720
2024
Q1 		$657K Buy
+64,815
New +$660K 0.01% 1526
2023
Q4 		– Sell
-67,202
Closed -$630K – 3071
2023
Q3 		$630K Buy
+67,202
New +$958K 0.01% 1559

Other funds holding VIR

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
GP
GSK plc London $599M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.66B AUM 340.85% 1-Year Est. Return